Enteric proinsulin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), GLP-1 promotes insulin production, reduces appetite, and maintains pancreatic -cell health
Peptide therapy is generally considered safe when prescribed by a qualified provider and monitored with proper lab work
Drp1 is primarily composed of four distinct structural domains: the amino-terminal GTPase structural domain, the variable structural domain, the helical structural domain situated in the middle, and the carboxy-terminal GTPase effector structural domain (Mishra and Chan, 2016)
Cell culture studies further reveal lowered lipid peroxidation and markers of reactive oxygen species following Epithalon exposureindicating a protective effect on cellular membranes and biomolecules
The systemic (subcutaneous) use described here is unproven and unapproved benefits seen with topical or in-vitro GHK-Cu should not be assumed to transfer to injection, and the safety of injected copper-peptide is not established
